Results: 2

1.
Figure 2

Figure 2. Correlation analysis of atorvastatin effects on cholesterol or CRP levels with C-peptide outcome.. From: Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial).

Of individual patients, the change of CRP concentrations (a) or total cholesterol concentrations (b) from baseline to 3 months of atorvastatin treatment (“delta”) were compared to stimulated C-peptide concentrations at 18 months (18 m).

Alexander Strom, et al. PLoS One. 2012;7(3):e33108.
2.
Figure 1

Figure 1. Correlation analysis of baseline CRP or total serum cholesterol concentrations with C-peptide outcome.. From: Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial).

Of individual patients, baseline CRP concentrations (a) or baseline total cholesterol levels (b) were compared to stimulated C-peptide concentrations at 18 months (18 m). The vertical line indicates the median of baseline CRP or cholesterol concentrations, respectively, the red line indicates the linear regression line obtained by the Pearson's correlation test.

Alexander Strom, et al. PLoS One. 2012;7(3):e33108.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk